Combined-modality treatment for locally advanced cervical cancer in a woman with Bloom-like syndrome: A case report and review of the literature

Strahlenther Onkol. 2023 Jan;199(1):102-105. doi: 10.1007/s00066-022-01981-8. Epub 2022 Aug 5.

Abstract

We report the case of a 46-year-old woman with Bloom-like syndrome affected with locally advanced cervical cancer. She was treated with induction chemotherapy and radical radiation therapy concurrent with chemotherapy (carboplatin and paclitaxel). She was able to complete treatment, but grade III toxicities were observed. The limited relevant literature is presented. We conclude that the management of patients with DNA repair deficiency is challenging for the team in charge because of the potentially high sensitivity to treatment and the lack of clear recommendations in the literature. The main objective remains to deliver the optimal treatment while reducing toxicities.

Keywords: Acute toxicity; DNA repair-deficiency disorders; Genetic disorders; Radiation therapy; Squamous cell carcinoma.

Publication types

  • Review
  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols* / therapeutic use
  • Carboplatin / therapeutic use
  • Combined Modality Therapy
  • Female
  • Humans
  • Middle Aged
  • Paclitaxel / therapeutic use
  • Uterine Cervical Neoplasms* / radiotherapy

Substances

  • Carboplatin
  • Paclitaxel